CD79B and aneurysmal bone cyst: While our study did not assess CD79b mutations, it is crucial to acknowledge the impact of hotspot mutations within the intracytoplasmic immunoreceptor tyrosine-based activation motif (ITAM) of CD79b, particularly identified in ABC DLBCLs, on the level of CD79b surface expression.